# PF 06412562 in Subjects With Advanced Stage Parkinson's Disease

> **NCT03665454** · PHASE1 · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 8 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** PF-06412562
- **DRUG:** Standard of Care Placebo

## Key facts

- **NCT ID:** NCT03665454
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-24
- **Primary completion:** 2019-03-21
- **Final completion:** 2019-04-21
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03665454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03665454, "PF 06412562 in Subjects With Advanced Stage Parkinson's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03665454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*